甘精胰岛素联合门冬胰岛素对血糖控制不佳的2型糖尿病患者临床疗效分析

邬培红

邬培红. 甘精胰岛素联合门冬胰岛素对血糖控制不佳的2型糖尿病患者临床疗效分析[J]. 实用临床医药杂志, 2013, (5): 99-101. DOI: 10.7619/jcmp.201305032
引用本文: 邬培红. 甘精胰岛素联合门冬胰岛素对血糖控制不佳的2型糖尿病患者临床疗效分析[J]. 实用临床医药杂志, 2013, (5): 99-101. DOI: 10.7619/jcmp.201305032
WU Peihong. Clinical effect of insulin glargine and insulin aspart on poorly controlled patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2013, (5): 99-101. DOI: 10.7619/jcmp.201305032
Citation: WU Peihong. Clinical effect of insulin glargine and insulin aspart on poorly controlled patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2013, (5): 99-101. DOI: 10.7619/jcmp.201305032

甘精胰岛素联合门冬胰岛素对血糖控制不佳的2型糖尿病患者临床疗效分析

基金项目: 中国高校医学期刊临床专项资金
详细信息
  • 中图分类号: R587.1

Clinical effect of insulin glargine and insulin aspart on poorly controlled patients with type 2 diabetes mellitus

  • 摘要: 目的 探讨甘精胰岛素联合门冬胰岛素治疗血糖控制不佳的2型糖尿病(T2DM)患者的临床疗效.方法 将86例T2DM患者随机分为2组,每组43例.观察组给予甘精胰岛素联合门冬胰岛素,对照组给予精蛋白生物合成人胰岛素联合生物合成人胰岛素.比较治疗3个月后2组空腹血糖(FPG)、餐后2h血糖(2 hPG)、糖化血红蛋白(HbAlc)水平的变化,以及血糖达标时间、体质量增加量、胰岛素日用量、血糖日波动量及低血糖发生率的差异.结果 观察组FPG、2hPG、HbAlc水平的改善幅度大于对照组;观察组血糖达标时间、体质量增加量、血糖日波动量及低血糖发生率均显著小于对照组.结论 对于血糖控制不佳的T2DM患者,甘精胰岛素与门冬胰岛素联合应用可理想控制血糖,减少体质量增加量,降低低血糖发生率,是安全而有效的胰岛素强化治疗方案.
  • Wasilewska M, Adamiec R. Cerebral regulation of insulin secretion and the development of insulin resistance in type 2 diabetes [J]. Adv Clin Exp Med, 2012(6):695.
    Wilson C. Metabolism:Iron metabolism, adiponectin and T2DM--the link with adipocyte insulin resistance [J]. Nat Rev Endocrino, 2012, (12):696.
    Rosengren A H, Braun M, Mahdi T. Reduced insulin exocytosis in human pancreatic β-cells with gene variants linked to type 2 diabetes [J]. Diabetes, 2012(7):1726.
    王伟杰. 2型糖尿病口服药物控制不佳改甘精胰岛素治疗的临床观察 [J]. 实用糖尿病杂志, 2012(2):29.
    Relimpio F, Guerrero R, Martínez-Brocca M A. HbA1c levels are better predicted by prebreakfast than postbreakfast blood glucose self-analyses in type 2 diabetes.Influence of duration of diabetes and mode of treatment [J]. ACTA DIABETOLOGICA, 2007(2):55.
    Boyle M E, Seifert K M, Beer K A. Guidelines for application of continuous subcutaneous insulin infusion (insulinpump) therapy in the perioperative period [J]. J Diabetes Sci Technol, 2012(1):184.
    Rendell M, Akturk H K, Tella S H. Glargine safety, diabetes and cancer [J]. Expert Opinion Drug Safety, 2013(2):247.
    Wu P, Ji C, Wang M. Desensitization of allergy to human insulin and its analogs by administering insulin aspart and insulin glargine [J]. Annals of Endocrinology(Paris), 2013(1):56.
    Ohta A, Arai K, Nishine A. Comparison of daily glucose excursion by continuous glucose monitoring between type 2 diabetic patients receiving preprandial insulin aspart or postprandial insulin glulisine [J]. Endocrine Journal, 2013(2):173.
    刘超, 王昆. 基础胰岛素与体质量增加的关系 [J]. 药品评价, 2011, (15):36.doi: 10.3969/j.issn.1672-2809.2011.15.008.
计量
  • 文章访问数:  202
  • HTML全文浏览量:  33
  • PDF下载量:  11
  • 被引次数: 0
出版历程
  • 发布日期:  2013-06-12

目录

    /

    返回文章
    返回
    x 关闭 永久关闭